Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;27(12):3097-3111.
doi: 10.1007/s11136-018-1931-3. Epub 2018 Jul 16.

Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study

Milea J M Timbergen  1   2 , Lonneke V van de Poll-Franse  3   4   5 , Dirk J Grünhagen  6 , Winette T van der Graaf  7   8 , Stefan Sleijfer  9 , Cornelis Verhoef  6 , Olga Husson  8
Affiliations
Review

Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study

Milea J M Timbergen et al. Qual Life Res. 2018 Dec.

Abstract

Purpose: Sporadic desmoid-type fibromatosis (DTF) is a rare, chronic, non-metastasising, disease of the soft tissues. It is characterised by local invasive and unpredictable growth behaviour and a high propensity of local recurrence after surgery thereby often having a great impact on health-related quality of life (HRQL). This study aims to review currently used HRQL measures and to asses HRQL issues among DTF patients.

Methods: A mixed methods methodology was used consisting of (1) a systematic literature review, according to the PRISMA guidelines (2009), using search terms related to sporadic DTF and HRQL in commonly used databases (e.g. Embase, Medline Ovid, Web of science, Cochrane Central, Psyc Info, and Google scholar), to provide an overview of measures previously used to evaluate HRQL among DTF patients; (2) focus groups to gain insight into HRQL issues experienced by DTF patients.

Results: The search strategy identified thirteen articles reporting HRQL measures using a wide variety of cancer-specific HRQL tools, functional scores, symptom scales (e.g. NRS), and single-item outcomes (e.g. pain and functional impairment). No DTF-specific HRQL tool was found. Qualitative analysis of three focus groups (6 males, 9 females) showed that participants emphasised the negative impact of DTF and/or its treatment on several HRQL domains. Six themes were identified: (1) diagnosis, (2) treatment, (3) follow-up and recurrence, (4) physical domain, (5) psychological and emotional domain, and (6) social domain.

Conclusion: A DTF-specific HRQL tool and consensus regarding the preferred measurement tool among DTF patients is lacking. Our study indicates that HRQL of DTF patients was negatively affected in several domains. A DTF-specific HRQL measure could improve our understanding of short- and long-term effects and, ideally, can be used in both clinic and for research purposes.

Keywords: Desmoid-type fibromatosis; Focus group; Health-related quality of life; Literature review.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approval from the Medical Ethics Committee of Erasmus MC in Rotterdam, the Netherlands was obtained for this study (file number MEC-2017-269).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Figures

Fig. 1
Fig. 1
Focus group guideline
See this image and copyright information in PMC

References

    1. World Health Organization (2016). International statistical classification of diseases and related health problems, 10th revision, volume 3.
    1. van Broekhoven DL, et al. Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: A population-based study. Annals of Surgical Oncology. 2015;22:2817–2823. doi: 10.1245/s10434-015-4632-y. - DOI - PMC - PubMed
    1. De Marchis ML, et al. Desmoid tumors in familial adenomatous polyposis. Anticancer Research. 2017;37:33573336. - PubMed
    1. Lips DJ, et al. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors) European Journal of Surgical Oncology. 2009;35:3–10. doi: 10.1016/j.ejso.2008.07.003. - DOI - PubMed
    1. Reitamo JJ, et al. The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. The American Journal of Surgery. 1986;151:230–237. doi: 10.1016/0002-9610(86)90076-0. - DOI - PubMed

Grants and funding

LinkOut - more resources